参考文献

1.冯晓燕，赵秀萍，张贺秋 .庚型肝炎病毒感染的研究进展 .中国输血杂志，2013，26（5）:488-491

2.姜晨晨，彭宗根 .HCV 感染实验动物模型的研究进展 .中国实验动物学报，2014，22（5）:87-94

3.张娜，刘学芳，赵君玫，等 .TTV 病毒感染与人类疾病 .现代预防医学，2013，40（17）:3289-3292

4.Allweiss L，Dandri M.Experimental in vitro and in vivo models for the study of human hepatitis B virus infection.J Hepatol，2016，64（Suppl 1）:S17-S31

5.Bility MT，Cheng L，Zhang Z，et al.Hepatitis B virus infection and immunopathogenesis in a humanized mouse model:induction of human-specific liver fibrosis and M2-like macrophages.PLoS Pathog，2014，10（3）:e1004032

6.Bility MT，Zhang L，Washburn ML，et al.Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis.Nat Protoc，2012，7（9）:1608-1617

7.Catanese MT，Dorner M.Advances in experimental systems to study hepatitis C virus in vitro and in vivo.Virology，2015，479-480:221-233

8.Chivero ET，Stapleton JT.Tropism of human pegivirus（formerly known as GB virus C/hepatitis G virus）and host immunomodulation:insights into a highly successful viral infection.J Gen Virol，2015，96（Pt 7）:1521-1532

9.Dandri M，Lutgehetmann M，Petersen J.Experimental models and therapeutic approaches for HBV.Semin Immunopathol，2013，35（1）:7-21

10.Eroubaix A，Osseman Q，Cassany A，et al.Expression of viral polymerase and phosphorylation of core protein determine core and capsid localization of the human hepatitis B virus.J Gen Virol，2015，96（Pt 1）:6717-6724

11.Douglas DN，Kneteman NM.Generation of improved mouse models for the study of hepatitis C virus.Eur J Pharmacol，2015，759:313-325

12.Elserag HB.Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma.Gastroenterology，2012，142（6）:1264-1273

13.Focosi D，Antonelli G，Pistello M，et al.Torquetenovirus:the human virome from bench to bedside.Clin Microbiol Infect，2016，22（7）:589-593

14.Forbi JC，Agwale SM，Ndip LM，et al.Genetic analysis of hepatitis A virus variants circulating among Children presenting with acute diarrhea in Cameroon.J Med Virol，2012，84（5），728-732

15.Gallegos-Orozco JF，Rakela-Brödner J.Hepatitis viruses:not always what it seems to be.Rev Med Chil，2010，138（10）:1302-1311

16.Gane EJ，Hyland RH，An D，et al.Efficacy of ledipasvir and sofosbuvir，with or without ribavirin，for 12 weeks in patients with HCV genotype 3 or 6 infection.Gastroenterology，2015，149（6）:1454

17.Giret MT，Kallas EG.GBV-C:state of the art and future prospects.Curr HIV/AIDS Rep，2012，9（1）:26-33

18.Hönerz S C，Pischke S，Schlue J，et al.Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection.Hepatology，2014，60（3）:1112-1113

19.Kamar N，Abravanel F，Lhomme S，et al.Hepatitis E virus:Chronic infection，extra-hepatic manifestations，and treatment.Clinics & Research in Hepatology&Gastroenterology，2015，39（1）:20-27

20.Kamar N，Bendall R，Legrand-Abravanel F，et al.Hepatitis E.Lancet，2012，379（9835）:2477-2488

21.Kew MC.Hepatitis viruses（other than hepatitis B and C viruses）as causes of hepatocellular carcinoma:an update.J Viral Hepat，2013，20（3）:149-157

22.Kim M，Choi B，Joo SY，et al.Generation of humanized liver mouse model by transplant of patient-derived fresh human hepatocytes.Transplant Proc，2014，46（4）:1186-1190

23.Lan HY，Zhao Y，Yang J，et al.Establishment of a novel triple-transgenic mouse:conditionally and liverspecifically expressing hepatitis C virus NS3/4A protease.Mol Biol Rep，2014，41（11）:7349-7359

24.Lankarani KB，Mahmoodi M，Honarvar B，et al.Determinants of poor outcome in patients with hepatitis A infection:a four-year retrospective study in Shiraz，Southern Iran.Arch Virol，2014，159（8）:1901-1907

25.Lindenbach BD，Murray CL，Thiel HJ，et al.Flaviviridae//Knipe DM，Howley PM.Fields Virology.6th ed.Philadelphia:Lipincott，2013:740-742

26.Liu K，Ludgate L，Yuan Z，et al.Regulation of Multiple Stages of Hepadnavirus Replication by the Carboxyl-Terminal Domain of Viral Core Protein in trans.J Virol，2014，89（5）:2918-2930

27.Manangeeswaran M，Jacques J，Tami C，et al.Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans.Gastroenterology，2012，142（7）:1516-1525

28.Manzin A，Mallus F，Macera L，et al.Global impact of Torque teno virus infection in wild and domesticated animals.J Infect Dev Ctries，2015，9（6）:562-570

29.Melhem NM，Talhouk R，Rachidi H，et al.Hepatitis A virus in the Middle East and North Africa region:a new challenge.J Viral Hepat，2014；21（9）:605-615

30.Meng XJ，Halbur PG，Haynes JS，et al.Experimental infection of pigs with the newly identified swine hepatitis E virus（swine HEV），but not with human strains of HEV.Arch Virol，1998，143（7）:1405-1415

31.Mohd HK，Groeger J，Flaxman AD，et al.Global epidemiology of hepatitis C virus infection:new estimates of age-specific antibody to HCV seroprevalence.Hepatology，2013，57（4）:1333-1342

32.Nahon P，Bourcier V，Layese R，et al.Eradication of Hepatitis C Virus Infection in Patients with Cirrhosis Reduces Risk of Liver and Non-Liver Complications.Gastroenterology，2017，152（1）:142-156

33.Ortega-Prieto AM，Dorner M.The expanding toolbox for hepatitis C virus research.J Viral Hepat，2016，23（5）:320-329

34.Piver E，Boyer A，Gaillard J，et al.Ultrastructural organization of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture.Gut，2017，66:1487-1495

35.Staff PP.Correction:Hepatitis B virus infection and immunopathogenesis in a humanized mouse model:induction of human-specific liver fibrosis and M2-like macrophages.PLoS Pathog，2015，11（3）:e1004718

36.Strick-Marchand H，Dusseaux M，Darche S，et al.A novel mouse model for stable engraftment of a human immune system and human hepatocytes.PLoS One，2015，10（3）:e0119820

37.Sureau C，Negro F.The hepatitis delta virus:Replication and pathogenesis.J Hepatol，2016，64（Suppl S1）:S102-S116

38.Thomas E，Liang TJ.Experimental models of hepatitis B and C-new insights and progress.Nat Rev Gastroenterol Hepatol，2016，13（6）:362-374

39.Tong S，Revill P.Overview of hepatitis B viral replication and genetic variability.Journal of Hepatology，2016，64（1）:S4-S16

40.Urban S.Liver capsule:Entry and entry inhibition of hepatitis B virus and hepatitis delta virus into hepatocytes.Hepatology，2016，63（2）:633

41.Ven NVD，Fortunak J，Simmons B，et al.Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus.Hepatology，2014，61（4）:1174-1182

42.Vercauteren K，de Jong YP，Meuleman P.Animal models for the study of HCV.Curr Opin Virol，2015，13:67-74

43.von Schaewen M，Ploss A.Murine models of hepatitis C:what can we look forward to？Antiviral Res，2014，104:15-22

44.Wakita T，Pietschmann T，Kato T，et al.Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.Nat Med，2005，11（7）:791-796

45.Wieland SF.The chimpanzee model for hepatitis B virus infection.Cold Spring Harb Perspect Med，2015，5（6）:a021469 4tUi39OaPPrBIGYUdz41jsEhpNBBnFW0E++D1bL8OVRTW/wBk2jPwNHKyF22mRis